WARRANT TO PURCHASE COMMON STOCK OF PALATIN TECHNOLOGIES, INC.Warrant Agreement • February 10th, 2017 • Palatin Technologies Inc • Pharmaceutical preparations • New York
THIS CERTIFIES THAT, for value received, ______________, or its permitted assigns (the “Holder”), is entitled to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation, or any successor (the “Company”), in whole or in part, at $0.70 per Warrant Share (subject to adjustment as set forth herein) (the “Warrant Purchase Price”), at any time during the period commencing on the date of issuance of this Warrant (as herein defined) and ending at 5:00 p.m., Eastern time, on August 4, 2021 (the “Expiration Date”), twelve thousand five hundred (12,500) shares of the Common Stock (as herein defined), in accordance with the terms thereof (as such number may be adjusted as provided herein, the “Warrant Shares”), subject to the provisions and upon the terms and conditions hereinafter set forth in this Warrant and all Warrants issued in exchange, transfer or replacement thereof (“Warrant”).
LICENSE AGREEMENT by and between AMAG PHARMACEUTICALS, INC. and PALATIN TECHNOLOGIES, INC. January 8, 2017License Agreement • February 10th, 2017 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is entered into as of January 8, 2017 (the “Execution Date”), by and between AMAG Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware and having a principal place of business at 1100 Winter Street, Waltham, MA 02451 (“AMAG”) and Palatin Technologies, Inc., a corporation organized and existing under the laws of Delaware and having a principal place of business at 4-B Cedar Brook Drive, Cedar Brook Corporate Center, Cranbury, NJ 08512 (“Palatin”). AMAG and Palatin may each be referred to herein individually as a “Party” and collectively as the “Parties.”
